Advertisement

Finland orders Sectra Tiger solution for communication of classified information

Source: Sectra, Defence Industry Europe

A Finnish authority has ordered units of the approved high assurance mobile encryption solution Sectra Tiger/S from international cybersecurity and medical imaging IT company Sectra. The solution enables users to securely and efficiently communicate classified information up to and including the classification level SECRET—information that could, if it were to fall into the wrong hands, severely damage the security of a nation or its allies.

“It is crucial for us to always be able to communicate classified information, regardless of where and when it is needed. Our users also need to feel confident in the products they are using when discussing sensitive topics. Hence, we chose Sectra’s encryption solution since it is approved and used by similar government organizations in other EU countries,” says a governmental official at the Finnish authority.



Sectra Tiger/S is a quantum-resilient mobile phone approved by national security authorities, NATO and the EU for use up to and including the classification level SECRET. It allows the user to share classified information through encrypted speech, messaging and data transfer. The solution offers high availability as it can utilize a variety of IP networks, such as satellite, fixed and mobile networks, for all types of communication.

“Given the unstable security situation in Europe, there is an increased need within many organizations for secure and approved solutions that can facilitate the exchange of highly classified information. This order shows that our solutions meet these high demands and thereby ensure that the exchanged information stays secure at all times. It is an honor to support the governmental officials in their daily work and to contribute to the information security of the Republic of Finland,” says Pekka Nurhonen, Vice President Sectra Communications OY.



 

 

Tags:

Advertisement

Advertisement

Advertisement

Related news & articles

Advertisement

Advertisement

Latest news

Advertisement

Advertisement

Featured

Advertisement